Janice Mehnert, Associate Director For Clinical Research at Perlmutter Cancer Center of NYU Langone Health/NYU Grossman School of Medicine, shared a post on LinkedIn by NYU Grossman School of Medicine, adding:
“Clearly I am late to this party but I just saw this post tonight!
My mentor and friend Jeff Weber, MD, PhD and I ran a course together (he led, I assisted) to teach our fellows how to write a competitive ASCO YIA. Our fellow turned faculty Peter Yu joined us. When Jeff passed away Catherine Diefenbach rolled up her sleeves to help me, and we pulled Shridar Ganesan into the mix. The result is a seminar that I truly love teaching along with my committed and brilliant colleagues and our talented fellows. We are insanely proud of our trainees.”
Quoting NYU Grossman School of Medicine’s post:
“NYU Grossman School of Medicine is proud to congratulate three faculty and trainees who have each received a 2026 Young Investigator Award from Conquer Cancer, the ASCO Foundation – one of oncology’s most prestigious early-career honors.
Ying Liu, MD, PhD is asking whether a targeted therapy that cures one form of leukemia can be rationally extended to patients with lung, colon, thyroid, and pancreatic cancers – using the same molecular mechanism against a broader family of cancer-driving proteins.
Morgan Simons, MD is investigating why combining immunotherapy with an IL-6 blocker improves outcomes and reduces serious side effects in advanced melanoma – and how to predict, before treatment begins, which patients will benefit most.
Herman van Besien, MD is working to unlock the immune signals that Epstein-Barr virus suppresses in lymphoma patients, so that specialized immune cells can finally recognize and attack tumors more effectively. Three distinct cancers. Three different mechanisms. One shared commitment to getting patients better answers, faster.
We are proud to see this work recognized on a national stage.”
Other articles featuring Janice Mehnert on OncoDaily.